ATE301991T1 - Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung - Google Patents

Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung

Info

Publication number: ATE301991T1
Authority: AT; Austria
Prior art keywords: hfc; container; carrier; administration; devices
Prior art date: 1996-12-04

Application number

AT97947786T

Other languages

English (en)

Inventor

Paul Mccarthy

Michael Goodman

Ake Lindahl

Original Assignee

Link Products Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-04

Filing date

1997-12-04

Publication date

2005-09-15

1996-12-04 Priority claimed from GBGB9625171.5A external-priority patent/GB9625171D0/en

1996-12-20 Priority claimed from GBGB9626449.4A external-priority patent/GB9626449D0/en

1997-12-04 Application filed by Link Products Ltd filed Critical Link Products Ltd

2005-09-15 Application granted granted Critical

2005-09-15 Publication of ATE301991T1 publication Critical patent/ATE301991T1/de

Links

239000000203 mixture Substances 0.000 title 1
YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000000443 aerosol Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
229960001760 dimethyl sulfoxide Drugs 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
229920001515 polyalkylene glycol Polymers 0.000 abstract 1
229920000728 polyester Polymers 0.000 abstract 1
229920005862 polyol Polymers 0.000 abstract 1
150000003077 polyols Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nozzles (AREA)

AT97947786T 1996-12-04 1997-12-04 Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung ATE301991T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9625171.5A GB9625171D0 (en)	1996-12-04	1996-12-04	Pharmaceutical compositions and devices for their administration
GBGB9626449.4A GB9626449D0 (en)	1996-12-20	1996-12-20	Pharmaceutical compositions and device for their administration
PCT/GB1997/003360 WO1998024420A1 (en)	1996-12-04	1997-12-04	Pharmaceutical compositions and devices for their administration

Publications (1)

Publication Number	Publication Date
ATE301991T1 true ATE301991T1 (de)	2005-09-15

Family

ID=26310542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97947786T ATE301991T1 (de)	1996-12-04	1997-12-04	Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung

Country Status (13)

Country	Link
EP (1)	EP1011646B1 (de)
JP (1)	JP2001505171A (de)
KR (1)	KR20000069275A (de)
AT (1)	ATE301991T1 (de)
AU (1)	AU726510B2 (de)
CA (1)	CA2273835A1 (de)
DE (1)	DE69734017T2 (de)
DK (1)	DK1011646T3 (de)
ES (1)	ES2244008T3 (de)
IE (1)	IES970858A2 (de)
NO (1)	NO992677L (de)
NZ (1)	NZ336049A (de)
WO (1)	WO1998024420A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9616237D0 (en)	1996-08-01	1996-09-11	Norton Healthcare Ltd	Aerosol formulations
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
GB2326334A (en) †	1997-06-13	1998-12-23	Chiesi Farma Spa	Pharmaceutical aerosol compositions
US6451285B2 (en)	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6509005B1 (en) *	1998-10-27	2003-01-21	Virginia Commonwealth University	Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
DZ2947A1 (fr)	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
US6290930B1 (en) *	1998-12-18	2001-09-18	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6315985B1 (en) *	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it)	1999-07-23	2002-09-09	Chiesi Farma Spa	Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
EP1143930B8 (de) *	1999-09-11	2008-03-19	Glaxo Group Limited	Fluticasonpropionat arzneizubereitung
GB2388843B (en) *	1999-09-11	2004-03-03	Glaxo Group Ltd	A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
AU2206801A (en) *	1999-12-24	2001-07-09	Alan Leslie Cripps	Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it)	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
DK1280515T3 (da)	2000-03-09	2007-06-11	Gw Pharma Ltd	Farmaceutiske sammensætninger omfattende cannabis
AU2000250701B2 (en) *	2000-05-22	2004-07-01	Chiesi Farmaceutici S.P.A.	Stable pharmaceutical solution formulations for pressurised metered dose inhalers
GB0015361D0 (en) *	2000-06-22	2000-08-16	Pharmasol Ltd	Improvements in pharmaceutical compositions
WO2001097780A2 (en) *	2000-06-22	2001-12-27	Pharmasol Ltd	Pharmaceutical compositions comprising an opioid analgesic
WO2002072067A2 (en) *	2001-03-12	2002-09-19	Glaxo Group Limited	Pharmaceutical aerosol formulation
TR200401980T4 (tr)	2001-07-02	2004-09-21	Chiesi Farmaceutici S.P.A.	Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
JP2005514437A (ja) *	2001-12-21	2005-05-19	スリーエムイノベイティブプロパティズカンパニー	イオン対複合体を含む医薬用エアロゾル製剤
EP1321159A1 (de) *	2001-12-21	2003-06-25	CHIESI FARMACEUTICI S.p.A.	Betätigungsvorrichtung für Druckdosierinhalator mit lasergebohrten Löchern
US7255102B2 (en)	2002-02-01	2007-08-14	Generex Pharmaceuticals Inc.	Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
EP1340492A1 (de) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
US7767698B2 (en)	2002-06-03	2010-08-03	Mcneil Ab	Formulation and use thereof
GB0311701D0 (en) *	2003-05-21	2003-06-25	Karib Kemi Pharm Liited	Improved metered dose inhaler product
AR041873A1 (es) *	2003-10-30	2005-06-01	Pablo Cassara Srl Lab	Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
EP1595531A1 (de)	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stabile Arzneimittellösung für Druckdosierinhalatoren
KR100776770B1 (ko) *	2006-07-18	2007-11-29	(주)비엔에프	고압분사 에어로졸 밸브
US8578942B2 (en) *	2010-05-25	2013-11-12	British American Tobacco (Investments) Limited	Aerosol generator
JP5409594B2 (ja) *	2010-12-22	2014-02-05	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	加圧式定量吸入器のための安定な製薬学的溶液製剤
RU2541312C2 (ru) *	2011-08-31	2015-02-10	Александр Васильевич Иващенко	Фармацевтическая композиция, способ ее получения и устройство для ее применения
JP6166453B2 (ja) *	2015-12-28	2017-07-19	花王株式会社	エアゾール化粧料
GB201912686D0 (en) *	2019-09-04	2019-10-16	Reown Pharma Inc	Pharmaceutical composition
KR102726961B1 (ko) *	2022-12-13	2024-11-06	주식회사 대웅제약	비강용 투약장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6907687A (en) *	1986-02-18	1987-08-20	Rorer Pharmaceutical Corporation	Composition for treatment of asthmatic conditions using phenoxymethyl quinolines
ATE114112T1 (de) *	1990-10-18	1994-12-15	Minnesota Mining & Mfg	Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
ATE339952T1 (de) *	1991-06-10	2006-10-15	Schering Corp	Fluorchlorkohlenwasserstofffreie aerosolformulierungen
FR2705570B1 (fr) *	1993-05-25	1995-07-13	Adir	Nouvelle formulation d'aérosol médicamentaux à base de fusafungine, son procédé de préparation et les compositions pharmaceutiques qui la contiennent.
TR199701170T1 (xx) *	1995-04-14	1998-02-21	Glaxo Wellcome Inc.	Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
GB9517998D0 (en) *	1995-09-04	1995-11-08	Bioglan Lab Ltd	Compositions and device for their administration

1997
- 1997-12-04 DE DE69734017T patent/DE69734017T2/de not_active Expired - Lifetime
- 1997-12-04 CA CA002273835A patent/CA2273835A1/en not_active Abandoned
- 1997-12-04 IE IE970858A patent/IES970858A2/en not_active IP Right Cessation
- 1997-12-04 JP JP52536298A patent/JP2001505171A/ja active Pending
- 1997-12-04 AU AU54028/98A patent/AU726510B2/en not_active Expired
- 1997-12-04 EP EP97947786A patent/EP1011646B1/de not_active Expired - Lifetime
- 1997-12-04 DK DK97947786T patent/DK1011646T3/da active
- 1997-12-04 NZ NZ336049A patent/NZ336049A/xx unknown
- 1997-12-04 AT AT97947786T patent/ATE301991T1/de not_active IP Right Cessation
- 1997-12-04 KR KR1019997004899A patent/KR20000069275A/ko not_active Withdrawn
- 1997-12-04 ES ES97947786T patent/ES2244008T3/es not_active Expired - Lifetime
- 1997-12-04 WO PCT/GB1997/003360 patent/WO1998024420A1/en not_active Ceased
1999
- 1999-06-02 NO NO992677A patent/NO992677L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2001505171A (ja)	2001-04-17
WO1998024420A1 (en)	1998-06-11
DK1011646T3 (da)	2005-09-19
NZ336049A (en)	2000-09-29
DE69734017T2 (de)	2006-06-14
ES2244008T3 (es)	2005-12-01
CA2273835A1 (en)	1998-06-11
NO992677D0 (no)	1999-06-02
IES80485B2 (en)	1998-08-12
EP1011646B1 (de)	2005-08-17
AU5402898A (en)	1998-06-29
KR20000069275A (ko)	2000-11-25
DE69734017D1 (de)	2005-09-22
EP1011646A1 (de)	2000-06-28
IES970858A2 (en)	1998-08-12
NO992677L (no)	1999-07-15
AU726510B2 (en)	2000-11-09

Legal Events

Date

Code

Title

Description

2006-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1011646

Country of ref document: EP

2010-09-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE301991T1 (de)	2005-09-15	Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung
US6413496B1 (en)	2002-07-02	Pharmaceutical compositions and devices for their administration
JP3266005B2 (ja)	2002-03-18	エアゾール製剤およびその製造方法
NZ509418A (en)	2003-06-30	Pharmaceutical formulations for aerosols with two or more active substances
EP2800571B1 (de)	2016-09-21	Oromukosala flüssige östradiol zusammensetzungen
US20120328718A1 (en)	2012-12-27	Pharmaceutical compositions
WO2001043722A3 (en)	2002-01-17	Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
NZ233415A (en)	1991-05-28	Pharmaceutical foam for rectal administration of 5-aminosalicylic acid; dispenser
AU601176B2 (en)	1990-09-06	Benzodiazepine aerosols
EP1277467A3 (de)	2003-04-16	Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
KR910007512A (ko)	1991-05-30	국소 약제 가압에어로졸 조성물 및 그를 함유한 에어로졸 콘테이너의 제조방법
GB2332372B (en)	2002-08-14	Pharmaceutical aerosol compositions
GEP20012462B (en)	2001-06-25	Composition for Aerosol Inhaler, Aerosol Inhaler and Method for Filling with the Composition
YU59899A (sh)	2002-06-19	Medicinski aerosolni proizvodi
ATE180665T1 (de)	1999-06-15	Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung
US6007834A (en)	1999-12-28	Nasal melatonin composition
KR970705997A (ko)	1997-11-03	N-{4-[2-(1, 2, 3, 4-테트라히드로-6, 7-디메톡시-2-이소퀴놀리닐)-에틸]-페닐}-9, 10-디히드로-5-메톡시-9-옥소-4-아크리딘 카르복사미드 화합물(gf120918a)을 포함하는 비경구 제약 조성물(parenteral pharmaceutical compositions containing gf120918a)
AU9221898A (en)	1999-03-29	Pharmaceutical coating composition and method of use
PE20020055A1 (es)	2002-02-12	Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
DE69803772D1 (de)	2002-03-21	Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
MX9604004A (es)	1997-12-31	Formualciones de farmaco en aerosol que contienen vitamina e.